These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37269016)

  • 1. Spatial distribution and multilevel analysis of factors associated with long-acting reversible contraceptive use among sexually active women of reproductive age in Nigeria.
    Bolarinwa OA; Ajayi KV; Okeke SR; Hailegebreal S; Odimegwu C
    Arch Public Health; 2023 Jun; 81(1):99. PubMed ID: 37269016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-acting reversible contraceptives use among adolescent girls and young women in high fertility countries in sub-Saharan Africa.
    Sambah F; Aboagye RG; Seidu AA; Tengan CL; Salihu T; Ahinkorah BO
    Reprod Health; 2022 Nov; 19(1):209. PubMed ID: 36384976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude and factors for method discontinuation and switching among long acting reversible contraceptive users in health facilities of Southern Ethiopia.
    Bereku T; Habtu Y; Abreham B; Ayele M; Eliso M
    Reprod Health; 2022 Feb; 19(1):47. PubMed ID: 35183214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial distribution and factors associated with modern contraceptive use among women of reproductive age in Nigeria: A multilevel analysis.
    Bolarinwa OA; Tessema ZT; Frimpong JB; Seidu AA; Ahinkorah BO
    PLoS One; 2021; 16(12):e0258844. PubMed ID: 34879066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting reversible contraceptive use in the post-abortion period among women seeking abortion in mainland China: intentions and barriers.
    Luo Z; Gao L; Anguzu R; Zhao J
    Reprod Health; 2018 May; 15(1):85. PubMed ID: 29793501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic variation and associated factors of long-acting contraceptive use among reproductive-age women in Ethiopia: a multi-level and spatial analysis of Ethiopian Demographic and Health Survey 2016 data.
    Ebrahim OA; Zeleke EG; Muluneh AG
    Reprod Health; 2021 Jun; 18(1):122. PubMed ID: 34112194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge and factors influencing long-acting reversible contraceptives use among women of reproductive age in Nigeria.
    Bolarinwa OA; Olagunju OS
    Gates Open Res; 2019; 3():7. PubMed ID: 32875280
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-Acting Reversible Contraception and Condom Use Among Female US High School Students: Implications for Sexually Transmitted Infection Prevention.
    Steiner RJ; Liddon N; Swartzendruber AL; Rasberry CN; Sales JM
    JAMA Pediatr; 2016 May; 170(5):428-34. PubMed ID: 26974492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reasons for Intent to Discontinue and Remove Long-Acting Reversible Contraceptives: National Survey of Family Growth 2017-2019.
    Poleon S; Thompson EL
    J Womens Health (Larchmt); 2022 May; 31(5):733-740. PubMed ID: 35005999
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes in the Use of Long-Acting Reversible Contraceptive Methods Among U.S. Nulliparous Women: Results from the 2006-2010, 2011-2013, and 2013-2015 National Survey of Family Growth.
    Ihongbe TO; Masho SW
    J Womens Health (Larchmt); 2018 Mar; 27(3):245-252. PubMed ID: 29148890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive method mix and preference: A focus on long acting reversible contraception in Urban Cameroon.
    Ajong AB; Njotang PN; Kenfack B; Essi MJ; Yakum MN; Iballa FBS; Mbu ER
    PLoS One; 2018; 13(8):e0202967. PubMed ID: 30138474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and associated factors of modern contraceptive discontinuation among sexually active married women in Nigeria.
    Kupoluyi JA; Solanke BL; Adetutu OM; Abe JO
    Contracept Reprod Med; 2023 Jan; 8(1):8. PubMed ID: 36635738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Women's sexual empowerment and utilization of long-acting reversible contraceptives in Ghana: evidence from the 2014 demographic and health survey.
    Adde KS; Appiah EA; Glozah FN; Tabong PT
    BMC Womens Health; 2023 Aug; 23(1):421. PubMed ID: 37559088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long acting reversible contraception use and associated factors among married women of reproductive age in Nepal.
    Bhandari R; Pokhrel KN; Gabrielle N; Amatya A
    PLoS One; 2019; 14(3):e0214590. PubMed ID: 30921403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and predictors of long-acting reversible contraceptive use among sexually active women in 26 sub-Saharan African countries.
    Bolarinwa OA; Nwagbara UI; Okyere J; Ahinkorah BO; Seidu AA; Ameyaw EK; Igharo V
    Int Health; 2022 Sep; 14(5):492-500. PubMed ID: 34405873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with early long-acting reversible contraceptives discontinuation in Ethiopia: evidence from the 2016 Ethiopian demographic and health survey.
    Fekadu GA; Omigbodun AO; Roberts OA; Yalew AW
    Arch Public Health; 2020; 78():36. PubMed ID: 32626577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.